Impact Factor Collection
Endocrine-Related Cancer’s 2019 Impact Factor has risen to 4.800, with the five-year measure now standing at 5.129.
This increase in Impact Factor reflects the high-quality research identified by the Editorial Board. The journal now ranks 25 out of 143 journals in the Endocrinology and Metabolism category, and 70 out of 244 in the Oncology category.
We extend our thanks profusely to the world-class Editors, authors and reviewers who make the journal what it is, and to Editor-in-Chief Professor Charis Eng for her leadership.
To recognise the new Impact Factor, the Editorial Team has put together a collection of articles that received the most citations in 2019, and contributed to this positive result.
All articles are freely available without subscription.
Highly cited in 2019
Long noncoding RNAs: emerging players in thyroid cancer pathogenesis
Avaniyapuram Kannan Murugan, Arasambattu Kannan Munirajan and Ali S Alzahrani
Anaplastic thyroid carcinoma: review of treatment protocols
Vera Tiedje et al.
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
Belinda van Zyl, Denise Tang and Nikola A Bowden
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
Yu-Tang Chin et al.
Treatment of refractory thyroid cancer
Amandine Berdelou et al.
Acquired resistance to aromatase inhibitors: where we stand!
Tiago Vieira Augusto et al.
Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors
Atsuko Kasajima et al.
TERT structural rearrangements in metastatic pheochromocytomas
Trisha Dwight et al.
TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours
Johan O Paulsson et al.
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules
Isabel Amendoeira, Tiago Maia and Manuel Sobrinho-Simões
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2)
Livia Lamartina et al.